Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
6 More presentations in this session
Doctor M. Groba Marco (Las Palmas de Gran Canaria, ES)
Mrs A. Robles Mezcua (Malaga, ES)
Doctor F. Ballacci (Udine, IT)
Doctor H. Unlugenc (Izmir, TR)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
